Dr Richard Hatchett, Chief Executive Officer of Coalition for Epidemic Preparedness Innovations (CEPI) has said that India’s concentration of talent and capability in the development of medicine, as well as its leadership in the G20 position, will transform how the country responds to future infectious diseases.
“We don’t know when and where the next disease is coming next. Closer interaction between humans and animals is going to be involved. We learn to live in this new era of epidemics and climate change. If we focus on innovation and collaboration, we can take on the challenge and even prevent the next pandemic,” he said in his plenary talk on the first day of BioAsia 2023.
CEPI has embarked on reducing vaccine development timelines to 100 days. “We proposed to develop a global library of prototype new vaccines. How do we use the global virus library if we haven’t encountered a virus before? The idea is to adapt a vaccine that we have against the new viruses quickly. We need a systematic preparedness that involves starting immediately, doing Phase 1 and 2 clinical trials, capturing data on safety and helping the regulators get to the point,” he said.
ALSO READ: PM Modi will inaugurate Shivamogga airport on February 27
Centre to develop ‘one nation, one policy’ for organ donation
India’s ingenuity has been in releasing vaccines on such a large scale in such a short period of time, saving millions of lives around the world. This reduced economic losses. He believes that India should collaborate to export its scientific and manufacturing know-how to the rest of the world.
(This story has been sourced from a third-party syndicated feed, agencies. Raavi Media accepts no responsibility or liability for the text’s dependability, trustworthiness, reliability, and data. Raavi Media management/ythisnews.com reserves the sole right to alter, delete or remove (without notice) the content at its absolute discretion for any reason whatsoever.)
